Back

Early aspirin withdrawal to P2Y12 monotherapy after PCI for ACS: a systematic review and meta-analysis of randomized controlled trials

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk Pharmacotherapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Marco Saffi

Hospital de Clínicas de Porto Alegre, Porto Alegre (Brazil)

6 More presentations in this session

Presentation thumbnail
Impact of intravascular imaging guidance on the effects of aspirin-free strategy for percutaneous coronary intervention for acute coronary syndrome: a post-hoc analysis from the STOPDAPT-3 trial
Doctor K. Takabayashi (Shiga, JP)
Abstract Slides Video
Presentation thumbnail
Temporal trends in the use of P2Y12 inhibitors over 15 years and their impact on in-hospital bleeding and mortality among patients with acute myocardial infarction in Switzerland
Mr J. Loosli (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Ticagrelor monotherapy vs. standard DAPT after PCI: an updated meta-analysis of early aspirin withdrawal
Doctor H. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of routine cardiovascular medications on contrast induced nephropathy post percutaneous coronary intervention: a national experience
Doctor O. Alameen (Doha, QA)
Abstract Slides Video
Presentation thumbnail
Timing of P2Y12 inhibitor administration in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis
Doctor T. Theodoropoulou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis
30 August 2025
thumbnail
Congress Presentation
Efficacy and safety of antithrombotic strategies for atrial fibrillation in patients with chronic coronary syndrome according to coronary treatment strategy: a meta-analysis of randomized trials
28 August 2026
thumbnail
Congress Presentation
Comparative efficacy of clopidogrel and aspirin monotherapy after dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
28 August 2026
thumbnail
Congress Presentation
Genotype-guided antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources